| Current price | $50.40 at the July 31, 2026 close, after-hours $50.65 | StockAnalysis CSX quote page | August 2, 2026 |
| Market capitalization | $93.36 billion reported, verified as about $93.24 billion from $50.40 x 1.85 billion shares with 0.13% deviation | StockAnalysis CSX statistics and financial_rigor.py | August 2, 2026 |
| Shares outstanding | 1.85 billion shares outstanding, down about 2.3% year over year | StockAnalysis CSX statistics | August 2, 2026 |
| Q2 2026 results | Record $3.94 billion revenue up 10%, $1.51 billion operating income up 17%, $1.00 billion net earnings up 21%, $0.54 diluted EPS up 23%, operating margin 38.3% up 240 bps, volume up 6% | CSX Q2 2026 press release | July 22, 2026 |
| FY2025 revenue | $14.09 billion, down 3.08% from $14.54 billion, cross-checked against StockAnalysis at $14.092 billion | StockAnalysis CSX financials | August 2, 2026 |
| FY2025 net income | About $2.89 billion from StockAnalysis, cross-checked with $1.54 EPS x 1.85 billion shares | StockAnalysis CSX financials | August 2, 2026 |
| TTM financials | TTM revenue $14.51 billion, operating income $4.96 billion, net income $3.22 billion, EPS $1.73 | StockAnalysis CSX financials | August 2, 2026 |
| Cash and total debt | Cash and short-term investments $1.39 billion against total debt $19.36 billion as of June 30, 2026; net debt about -$17.97 billion | StockAnalysis CSX balance sheet | August 1, 2026 |
| Free cash flow | TTM operating cash flow $5.19 billion, capital expenditures $2.57 billion, free cash flow $2.62 billion | StockAnalysis CSX cash flow statement | August 1, 2026 |
| Valuation ratios | 29.13x PE, 23.53x forward PE, 6.43x sales, 6.67x book, 33.38x free cash flow, 1.11% dividend yield using financial_rigor.py | StockAnalysis CSX statistics and Pineify financial_rigor.py | August 2, 2026 |
| Analyst consensus | Buy with an average price target of $52.85 across 25 analysts, low $32 and high $60 | StockAnalysis CSX forecast | July 31, 2026 |
| FY2026 and FY2027 estimates | FY2026 revenue estimate $15.17 billion with EPS $2.00, FY2027 revenue estimate $15.90 billion with EPS $2.26 | StockAnalysis CSX forecast | July 31, 2026 |
| Recent analyst actions | Argus to $56, Deutsche Bank to $59, J.P. Morgan to $58, Barclays to $60, Citi to $54, RBC to $54, BofA to $56 after the Q2 2026 beat | StockAnalysis CSX forecast and TipRanks | July 31, 2026 |
| Short interest | 36.97 million shares short, 2.00% of shares outstanding, 3.09 days to cover | StockAnalysis CSX statistics | August 2, 2026 |
| Technical snapshot | 20-day MA near $50.27, 50-day MA near $48.13, 200-day MA near $41.31, 14-day RSI near 54.5 | Barchart CSX technical analysis | July 31, 2026 |
| CEO | Steve Angel serves as president and CEO, appointed in September 2025, and continues to lead the Q2 2026 margin and volume expansion | CSX investor management page | August 2, 2026 |